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Abstract 
A fully diastereoselective total synthesis of the lycorenine-type Amaryllidaceae alkaloid (±)-clivonine 
(19) is reported via a route that employs for the first time a biomimetic ring switch from a lycorine-type 
progenitor, thereby corroborating experimentally the biogenetic hypothesis first expounded for these 
compounds by Barton in 1960. 
Introduction 
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The Amaryllidaceae alkaloids are a large class of naturally occurring bases isolated from herbaceous 
perennials such as daffodils that can mostly be classified as belonging to one of eight skeletally distinct 
sub-classes.1 All these alkaloids derive from a common bisphenol biosynthetic precursor, norbelladine 
(1, itself derived from Phe and Tyr).2 This biogenetic scheme was first enunciated by Barton in 1957.3 
He used the Amaryllidaceae alkaloids to illustrate his thesis that intramolecular phenolic oxidative 
coupling constituted a critical diversifying step in alkaloid biosynthesis; an idea that proved correct and 
revolutionized our understanding of alkaloid biogenesis.2 Initially, Barton was unable to account for the 
tazettine4 and lycorenine sub-classes within this regime, proposing that these compounds were possibly 
derived from intermolecular phenolic coupling,3 but in 1960 he revised his proposal to encompass their 
formation by rearrangement of haemanthamine (2) and lycorine-type (I) progenitors respectively.5 
Interconversion was proposed to involve benzylic oxidation (→ lactamols 3 and II) then ring-
opening/bond rotation/ring closure/N-methylation (→ lactols 4 and III), a process we will refer to as 
‘ring–switching’. An intramolecular crossed-Cannizzaro rearrangement (during isolation)6,7c accounts 
for the conversion of pretazettine (4) to tazettine (5) whereas lactol III to lactone IV oxidation occurs in 
the lycorenine series (Scheme 1). 
 
Scheme 1. Outline biosynthesis of tazettine and lycorenine type alkaloids from norbelladine (1) via 
‘ring switching’. NB. Precise structures and non-essential stereochemistry omitted from I-IV. 
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Wildman subsequently corroborated these hypotheses by tritium feeding experiments in Sprekelia 
formosissima for tazettine (5)8 and in Narcissus ‘King Alfred’ for lycorenine.9 Moreover, Wildman 
developed a biomimetic protocol for the synthesis of pretazettine (4) from haemanthidine (3)6 which has 
been employed in all but two10 subsequent total syntheses of tazettine7 and pretazettine.11 However, 
Wildman was unable to develop a corresponding protocol for biomimetic conversion of lycorine to 
lycorenine-type ring systems (I → IV), noting that this conversion requires a ~180° rotation and 
minimal relief of strain as compared to a ~90° rotation accompanied by significant relief of strain in the 
haemanthidine/pretazettine series (3 → 4).6,7c,9 Consequently, although Mizukami and Kotera have 
developed a multi-step, non-biomimetic synthetic sequence for this type of interconversion based on the 
von Braun reaction,12 Barton’s original hypothesis remains synthetically unverified. Herein we describe 
a concise, fully diastereoselective total synthesis of the lycorenine-type Amaryllidaceae alkaloid (±)-
clivonine (19) from a lycorine-type progenitor 17 in which this key transformation has finally been 
accomplished. 
Results and Discussion 
Clivonine (19) was isolated and characterized from Clivia miniata Regel in 1956 by Wildman13 and 
its relative and absolute stereochemistry was established by Jeffs et al. in 1971.14,15 To date, the only 
synthesis of (±)-clivonine has been that of Irie in 1973 (17 steps, 0.43% overall yield from piperonal).16  
The synthesis of (±)-clivonine progenitor 15 parallels our previous synthesis of (+)-trianthine (16), 
employing a retro-Cope elimination17 (11 → 12) as the key step (Scheme 2).18 
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Scheme 2. Synthesis of clivonine progenitor 15. 
Although trianthine (16) and clivonine progenitor 15 both have trans B-C/cis C-D ring-junctions they 
are diastereomeric with respect to the ring C cis-diol motif. Consequently, following 1,2-addition of aryl 
lithium reagent to the convex face of bicyclic enone (±)-619,20 and trapping as acetate 7 (92% yield), a 
one-pot Ireland-Claisen rearrangement/CH2N2 esterification was employed to relay the stereochemistry 
at C11b to C3a with retention of configuration (→ 8, 85% yield; cf. the vinyl cuprate SN2’ displacement 
with inversion of configuration employed for trianthine)18a. Ester to aldehyde reduction (DIBAL-H) 
then oximation (NH2OH.HCl, 82% yield, 2 steps) and oxime reduction (NaCNBH3) then afforded retro-
Cope elimination substrate 11 (83% yield). Hydroxylamine 11 cyclized smoothly upon heating as a 
0.014 M solution in degassed toluene at 80 °C for 17 h to provide N-hydroxyhydrindole 12 as a single 
stereoisomer in 98% yield.18a Hydrogenolysis of the N-O bond (Raney-Ni, 94% yield), N-formylation 
(HCO2COMe, 93% yield) and then Bischler-Napieralski ring B closure with concomitant acetonide 
deprotection (POCl3) gave water soluble iminium salt 15 after purification by ion-exchange then C18 
reverse-phase solid phase extraction (SPE) (42% yield). 
Prior studies in which we had been unable to obtain lactamol 17 cleanly, via lactam half-reduction 
(LiEtBH3) or via Polonovski reactions from the amine-N-oxide (Ac2O or TFAA), had taught us that 
lactamol 17 was extremely sensitive to Cannizzaro disproportionation to give a 1:1 mixture of the 
corresponding amine and lactam, particularly under basic conditions. Attempts to transform iminium 
salt 15 into the corresponding N-methyl aldehyde according to a procedure developed by Rozwadowska 
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for hydrastinine using MeI in MeOH,21,22 and into lactamol 17 according to procedures developed by 
Dostál for sanguinarine using NaOD in d3-MeCN/D2O)23 or Na2CO3/D2O,24 also induced substantial 
disproportionation. However, treatment of a solution of iminium salt 15 in d6-DMSO/D2O (5:1 v/v) with 
a solution of Cs2CO3 in D2O (0.77 M, 1.3 equiv.) reproducibly gave clean conversion to a single, 
unassigned epimer of lactamol 17 in ~5 min, as evidenced by 1H NMR spectroscopy (15 iminium 
methine: s @ δ ~9.07 ppm → 17 lactamol methine: s @ δ ~4.92 ppm) (Scheme 3). 
 
Scheme 3. Biomimetic ring-switch of lycorine-type progenitor 17 into clivonine (19) and the molecular 
structure of 19·HCl (X-ray). 
Next, we explored N-methylation. Wildman6 described two protocols for conversion of haemanthidine 
(3) to pretazettine (4): N-methiodide salt formation (MeI in MeOH) then careful basification of an 
aqueous acidic solution of this salt with K2CO3 and extraction into CHCl3 was the method adopted (with 
modifications)7,11 in subsequent syntheses, but Eschweiler-Clarke reductive methylation 
(HCO2H/H2CO) then basification and extraction was reportedly equally efficient. In our hands, the 
Eschweiler-Clarke method returned only the corresponding amine when applied to lactamol 17 whereas 
treatment with methanolic MeI gave a complex mixture of products containing methyl ether/acetal 
signals by 1H NMR spectroscopy. Extensive experimentation established that addition of just 1 equiv. of 
a dilute solution of MeI in d6-DMSO to freshly prepared solution of lactamol 17/Cs2CO3 (in d6-
DMSO/D2O) afforded a mixture of species of which the major component was tentatively assigned as 
N-methyl aldehyde 18 by 1H NMR spectroscopy (aldehyde proton: s @ δ ~9.67 ppm, N-Me: s @ δ 
~2.35 ppm). Further optimization was confounded by the formation of what appeared to be quaternised 
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salts which were also formed to a greater extent when employing alternative methylating agents (e.g. 
Me2SO4, MeOTf). However, freeze-drying of this mixture, suspension of the residue in toluene and 
treatment with Fetizon’s reagent reproducibly afforded (±)-clivonine (19) in 32% yield after 
chromatography from iminium salt 15 (12 steps, 6.1% overall yield from enone 6). All spectroscopic 
data matched that reported for the natural material14,15,25 and its molecular structure was confirmed by a 
single-crystal X-ray structure determination on its hydrochloride (Scheme 3). 
Conclusion 
In conclusion, we have reported the total synthesis of the lycorenine-type Amaryllidaceae alkaloid 
(±)-clivonine (19) via a route that employs, for the first time, a biomimetic ring switch from a lycorine-
type progenitor, thereby finally corroborating experimentally the biogenetic hypothesis first expounded 
for these compounds by Barton 50 years ago. 
We are currently exploring this approach for the synthesis of hippeastrine from lycorine1 and 
investigating whether there is a causal relationship between ring-switching and the life-cycle of the 
herbaceous perennials in which these alkaloids are found.26 
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